Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials

被引：141
作者：
Wang, Li-Tzu [1 ,2 ]
Ting, Chiao-Hsuan [1 ]
Yen, Men-Luh [3 ,4 ]
Liu, Ko-Jiunn [5 ]
Sytwu, Huey-Kang [2 ,6 ]
Wu, Kenneth K. [1 ,7 ]
Yen, B. Linju [1 ]
机构：
[1] Natl Hlth Res Inst, Inst Cellular & Syst Med, Regenerat Med Res Grp, 35 Keyan Rd, Zhunan 35053, Taiwan
[2] NDMC, Grad Inst Life Sci, Taipei, Taiwan
[3] Natl Taiwan Univ Hosp, Dept Ob Gyn, Taipei, Taiwan
[4] Natl Taiwan Univ, Coll Med, Taipei, Taiwan
[5] NHRI, Natl Inst Canc Res, Tainan, Taiwan
[6] NDMC, Grad Inst Microbiol & Immunol, Taipei, Taiwan
[7] China Med Coll, Grad Inst Basic Med Sci, Taichung, Taiwan
来源：
JOURNAL OF BIOMEDICAL SCIENCE | 2016年 / 23卷
关键词：
Mesenchymal stem cells; Human; Immunomodulation; Inflammation; Clinical trials; Autoimmune disease; Organ transplantation and rejection; Stem cell therapy; VERSUS-HOST-DISEASE; ACUTE LUNG INJURY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; ALLERGIC AIRWAY INFLAMMATION; DSS-INDUCED COLITIS; STROMAL CELLS; MOUSE MODEL; CROHNS-DISEASE; IN-VITRO; LYMPHOCYTE-PROLIFERATION;
D O I：
10.1186/s12929-016-0289-5
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
Human mesenchymal stem cells (MSCs) are multilineage somatic progenitor/stem cells that have been shown to possess immunomodulatory properties in recent years. Initially met with much skepticism, MSC immunomodulation has now been well reproduced across tissue sources and species to be clinically relevant. This has opened up the use of these versatile cells for application as 3rd party/allogeneic use in cell replacement/tissue regeneration, as well as for immune-and inflammation-mediated disease entities. Most surprisingly, use of MSCs for in immune-/inflammation-mediated diseases appears to yield more efficacy than for regenerative medicine, since engraftment of the exogenous cell does not appear necessary. In this review, we focus on this non-traditional clinical use of a tissue-specific stem cell, and highlight important findings and trends in this exciting area of stem cell therapy.
引用
收藏
页码：1 / 13
页数：13
相关论文
共 148 条
  • [1] In vivo contribution of murine mesenchymal stem cells into multiple cell-types under minimal damage conditions
    Anjos-Afonso, F
    Siapati, EK
    Bonnet, D
    [J]. JOURNAL OF CELL SCIENCE, 2004, 117 (23) : 5655 - 5664
  • [2] Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway
    Augello, A
    Tasso, R
    Negrini, SM
    Amateis, A
    Indiveri, F
    Cancedda, R
    Pennesi, G
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (05) : 1482 - 1490
  • [3] Human Mesenchymal Stromal Cells Attenuate Graft-Versus-Host Disease and Maintain Graft-Versus-Leukemia Activity Following Experimental Allogeneic Bone Marrow Transplantation
    Auletta, Jeffery J.
    Eid, Saada K.
    Wuttisarnwattana, Patiwet
    Silva, Ines
    Metheny, Leland
    Keller, Matthew D.
    Guardia-Wolff, Rocio
    Liu, Chen
    Wang, Fangjing
    Bowen, Theodore
    Lee, Zhenghong
    Solchaga, Luis A.
    Ganguly, Sudipto
    Tyler, Megan
    Wilson, David L.
    Cooke, Kenneth R.
    [J]. STEM CELLS, 2015, 33 (02) : 601 - 614
  • [4] Human Bone Marrow-Derived Mesenchymal Stem Cells Induce Th2-Polarized Immune Response and Promote Endogenous Repair in Animal Models of Multiple Sclerosis
    Bai, Lianhua
    Lennon, Donald P.
    Eaton, Valerie
    Maier, Kari
    Caplan, Arnold I.
    Miller, Stephen D.
    Miller, Robert H.
    [J]. GLIA, 2009, 57 (11) : 1192 - 1203
  • [5] FAST AND FURIOUS
    Baker, Monya
    [J]. NATURE, 2009, 458 (7241) : 962 - 965
  • [6] Mediators of chronic obstructive pulmonary disease
    Barnes, PJ
    [J]. PHARMACOLOGICAL REVIEWS, 2004, 56 (04) : 515 - 548
  • [7] Cotransplantation of Mesenchymal Stem Cells Might Prevent Death from Graft-versus-Host Disease (GVHD) without Abrogating Graft-versus-Tumor Effects after HLA-Mismatched Allogeneic Transplantation following Nonmyeloablative Conditioning
    Baron, Frederic
    Lechanteur, Chantal
    Willems, Evelyne
    Bruck, France
    Baudoux, Etienne
    Seidel, Laurence
    Vanbellinghen, Jean-Francois
    Hafraoui, Kaoutar
    Lejeune, Marie
    Gothot, Andre
    Fillet, Georges
    Beguin, Yves
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (06) : 838 - 847
  • [8] Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo
    Bartholomew, A
    Sturgeon, C
    Siatskas, M
    Ferrer, K
    McIntosh, K
    Patil, S
    Hardy, W
    Devine, S
    Ucker, D
    Deans, R
    Moseley, A
    Hoffman, R
    [J]. EXPERIMENTAL HEMATOLOGY, 2002, 30 (01) : 42 - 48
  • [9] T cells from autoimmune patients display reduced sensitivity to immunoregulation by mesenchymal stem cells: Role of IL-2
    Ben-Ami, Eyal
    Miller, Ariel
    Berrih-Aknin, Sonia
    [J]. AUTOIMMUNITY REVIEWS, 2014, 13 (02) : 187 - 196
  • [10] Synovial tissue inflammation in early and late osteoarthritis
    Benito, MJ
    Veale, DJ
    Fitzgerald, O
    van den Berg, WB
    Bresnihan, B
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (09) : 1263 - 1267
12345678910